616 related articles for article (PubMed ID: 19618757)
1. Renin-angiotensin system inhibitors in proteinuric chronic kidney disease.
Hirsch S
Compr Ther; 2009; 35(2):91-5. PubMed ID: 19618757
[TBL] [Abstract][Full Text] [Related]
2. Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need?
Lim S
Acta Med Indones; 2008 Jan; 40(1):34-7. PubMed ID: 19054878
[TBL] [Abstract][Full Text] [Related]
3. [Progression of chronic renal insufficiency and its prevention using angiotensin converting enzyme inhibitors and angiotensin antagonists].
Tesar V
Vnitr Lek; 2003 May; 49(5):365-9. PubMed ID: 12908169
[TBL] [Abstract][Full Text] [Related]
4. [Can blockade of the renin-angiotensin system be optimised in proteinuric nephropathies?].
Juárez GF
Nefrologia; 2008; 28(4):381-4. PubMed ID: 18662145
[No Abstract] [Full Text] [Related]
5. Rationale for combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor treatment and end-organ protection in patients with chronic kidney disease.
Toto R; Palmer BF
Am J Nephrol; 2008; 28(3):372-80. PubMed ID: 18073461
[TBL] [Abstract][Full Text] [Related]
6. Arterial hypertension and proteinuria in pediatric chronic kidney disease.
Simonetti GD; Bucher BS; Tschumi S; Lava SA; Bianchetti MG
Minerva Pediatr; 2012 Apr; 64(2):171-82. PubMed ID: 22495191
[TBL] [Abstract][Full Text] [Related]
7. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
Krum H; Gilbert RE
J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
[TBL] [Abstract][Full Text] [Related]
8. Is there added value to adding ARB to ACE inhibitors in the management of CKD?
Cohen DL; Townsend RR
J Am Soc Nephrol; 2009 Aug; 20(8):1666-8. PubMed ID: 18776118
[TBL] [Abstract][Full Text] [Related]
9. Supratherapeutic doses of angiotensin receptor blockers to decrease proteinuria in patients with chronic kidney disease.
Palmer BF
Am J Nephrol; 2008; 28(3):381-90. PubMed ID: 18063856
[TBL] [Abstract][Full Text] [Related]
10. Progression of renal disease: renoprotective specificity of renin-angiotensin system blockade.
Griffin KA; Bidani AK
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1054-65. PubMed ID: 17699327
[TBL] [Abstract][Full Text] [Related]
11. Aliskiren combined with losartan in diabetes and nephropathy.
Lindner T
N Engl J Med; 2008 Sep; 359(10):1068-9; author reply 1069-70. PubMed ID: 18777612
[No Abstract] [Full Text] [Related]
12. [Therapeutic possibilities for the inhibition of the renin-angiotensin-aldosterone system].
Abrahám G; Légrády P
Orv Hetil; 2003 May; 144(18 Suppl 1):892-5. PubMed ID: 12785232
[TBL] [Abstract][Full Text] [Related]
13. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease.
Brewster UC; Perazella MA
Am J Med; 2004 Feb; 116(4):263-72. PubMed ID: 14969655
[TBL] [Abstract][Full Text] [Related]
14. [Blocking the renin-angiotensin system in chronic kidney disease].
Segura J
Nefrologia; 2004; 24 Suppl(6):101-12, 187-235. PubMed ID: 15696901
[No Abstract] [Full Text] [Related]
15. Progression of chronic kidney disease: can it be prevented or arrested?
Jaber BL; Madias NE
Am J Med; 2005 Dec; 118(12):1323-30. PubMed ID: 16378772
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension due to primary aldosteronism: a case for exclusion.
Bubbar CD; Blackburn DF; Wilson MP; Wilson TW
Ann Pharmacother; 2007 Jan; 41(1):129-32. PubMed ID: 17179189
[TBL] [Abstract][Full Text] [Related]
17. Complementary effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in slowing the progression of chronic kidney disease.
Ripley E
Am Heart J; 2009 Jun; 157(6 Suppl):S7-S16. PubMed ID: 19450722
[TBL] [Abstract][Full Text] [Related]
18. Importance of blood pressure control in chronic kidney disease.
Ravera M; Re M; Deferrari L; Vettoretti S; Deferrari G
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S98-103. PubMed ID: 16565257
[TBL] [Abstract][Full Text] [Related]
19. The case for dual Renin-Angiotensin system inhibition.
Hirsch S
Arch Intern Med; 2009 Nov; 169(20):1931; author reply 1931. PubMed ID: 19901153
[No Abstract] [Full Text] [Related]
20. Toward better renoprotection: lessons from angiotensin receptor blockers.
Miyata T; Takizawa S
Hemodial Int; 2007 Apr; 11(2):164-8. PubMed ID: 17403166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
